Ursodeoxycholic acid treatment in primary sclerosing cholangitis

James H. Tabibian, Keith Lindor

Research output: Chapter in Book/Report/Conference proceedingChapter

3 Scopus citations


Primary sclerosing cholangitis (PSC) is a chronic, idiopathic liver disease which, despite extensive laboratory-based investigation, translational studies, and clinical trials, lacks established medical treatment. In this chapter, we provide a succinct, comprehensive review of research regarding the potential role for ursodeoxycholic acid as a pharmacotherapy for PSC.

Original languageEnglish (US)
Title of host publicationPrimary Sclerosing Cholangitis
Subtitle of host publicationCurrent Understanding, Management, and Future Developments
PublisherSpringer International Publishing
Number of pages8
ISBN (Electronic)9783319409085
ISBN (Print)9783319409061
StatePublished - Jan 1 2016


  • Algorithm
  • Bile acids
  • Biliary tract diseases
  • Cholestasis
  • Cholestatic liver disease
  • Medical management
  • Outcomes
  • Pharmacotherapy
  • Pruritus
  • Quality of life

ASJC Scopus subject areas

  • General Medicine


Dive into the research topics of 'Ursodeoxycholic acid treatment in primary sclerosing cholangitis'. Together they form a unique fingerprint.

Cite this